On the public citation graph
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
0 signed · 154 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.149.12.2733openalex-snapshot
Polyvalent Immune Globulin and Cytomegalovirus Infection After Renal Transplantation
inferredcites →https://doi.org/10.1001/archsurg.1988.01400360072012openalex-snapshot
Prophylaxis of Serious Cytomegalovirus Infection in Renal Transplant Candidates Using Live Human Cytomegalovirus Vaccine
inferredcites →https://doi.org/10.1001/archsurg.1992.01420010065009openalex-snapshot
A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy
inferredcites →https://doi.org/10.1001/archsurg.1994.01420280121016openalex-snapshot
Prophylaxis of Primary Cytomegalovirus Disease in Renal Transplant Recipients
inferredcites →https://doi.org/10.1001/jama.1989.03420240075030openalex-snapshot
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
inferredcites →https://doi.org/10.1001/jama.1989.03420240121038openalex-snapshot
The Indirect Effects of Cytomegalovirus Infection on the Outcome of Organ Transplantation
inferredcites →https://doi.org/10.1001/jama.1995.03520290060030openalex-snapshot
Empirical Evidence of Bias
inferredcites →https://doi.org/10.1001/jama.273.5.408openalex-snapshot
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
inferredcites →https://doi.org/10.1002/14651858.cd003774.pub3openalex-snapshot
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
inferredcites →https://doi.org/10.1002/14651858.cd003774.pub4openalex-snapshot
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
inferredcites →https://doi.org/10.1002/14651858.cd005133.pub2openalex-snapshot
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
inferredcites →https://doi.org/10.1002/14651858.cd005133.pub3openalex-snapshot
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
inferredcites →https://doi.org/10.1007/978-3-642-77423-2_46openalex-snapshot
CMV prophylaxis after renal transplantation with immunoglobulin or CMV-hyperimmunoglobulin — a prospective clinical trial
inferredcites →https://doi.org/10.1007/bf00336637openalex-snapshot
Early detection of primary cytomegalovirus infection after heart and kidney transplantation and the influence of hyperimmune globulin prophylaxis
inferredcites →https://doi.org/10.1007/bf00918365openalex-snapshot
Cytomegalovirus infection in heart transplant recipients: Preliminary results of a controlled trial of intravenous gamma globulin
inferredcites →https://doi.org/10.1016/0002-9343(93)90279-xopenalex-snapshot
Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants
inferredcites →https://doi.org/10.1016/j.healun.2004.11.016openalex-snapshot
The Impact of CytoGam on Cardiac Transplant Recipients With Moderate Hypogammaglobulinemia: A Randomized Single-Center Study
inferredcites →https://doi.org/10.1016/s0041-1345(01)02671-9openalex-snapshot
Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy
inferredcites →https://doi.org/10.1016/s0140-6736(00)02350-3openalex-snapshot
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
inferredcites →https://doi.org/10.1016/s0140-6736(05)66553-1openalex-snapshot
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
inferredcites →https://doi.org/10.1016/s0140-6736(83)92215-8openalex-snapshot
ENDEMIC EPILEPSY IN AN ISOLATED REGION OF LIBERIA
inferredcites →https://doi.org/10.1016/s0140-6736(84)90930-9openalex-snapshot
TOWNE-VACCINE-INDUCED PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL TRANSPLANTS
inferredcites →https://doi.org/10.1016/s0140-6736(98)01085-xopenalex-snapshot
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
inferredcites →https://doi.org/10.1016/s0166-3542(98)00050-3openalex-snapshot
Immune globulin versus antivirals versus combination for prevention of cytomegalovirus disease in transplant recipients
inferredcites →https://doi.org/10.1016/s0891-5520(20)30708-xopenalex-snapshot
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
inferredcites →https://doi.org/10.1016/s0891-5520(20)30713-3openalex-snapshot
PNEUMOCYSTIS CARINII AND PARASITIC INFECTIONS IN TRANSPLANTATION
inferredcites →https://doi.org/10.1016/s0891-5520(20)30714-5openalex-snapshot
FUNGAL INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS
inferredcites →https://doi.org/10.1016/s1053-2498(02)00648-4openalex-snapshot
Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients
inferredcites →https://doi.org/10.1055/s-2008-1068148openalex-snapshot
CMV-Hyperimmunglobulinprophylaxe nach Nierentransplantation: Ergebnisse einer prospektiv randomisierten Studie
inferredcites →https://doi.org/10.1056/nejm197906143002401openalex-snapshot
Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal Transplantation
inferredcites →https://doi.org/10.1056/nejm198306233082501openalex-snapshot
Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant Recipients
inferredcites →https://doi.org/10.1056/nejm198710223171703openalex-snapshot
Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients
inferredcites →https://doi.org/10.1056/nejm199806113382407openalex-snapshot
Infection in Organ-Transplant Recipients
inferredcites →https://doi.org/10.1086/324585openalex-snapshot
:Management of Infections in Immunocompromised Patients
inferredcites →https://doi.org/10.1086/516095openalex-snapshot
Randomized Comparison of Ganciclovir Plus Intravenous Immune Globulin (IVIG) with IVIG Alone for Prevention of Primary Cytomegalovirus Disease in Children Receiving Liver Transplants
inferredcites →https://doi.org/10.1093/ndt/7.12.1230openalex-snapshot
Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients
inferredcites →https://doi.org/10.1097/00007890-198802000-00031openalex-snapshot
ADVERSE EFFECT OF LOW-DOSE PROPHYLACTIC HUMAN RECOMBINANT LEUKOCYTE INTERFERON-ALPHA TREATMENT IN RENAL TRANSPLANT RECIPIENTS
inferredcites →https://doi.org/10.1097/00007890-198908000-00016openalex-snapshot
PREVENTION OF CYTOMEGALOVIRUS-RELATED DEATH BY PASSIVE IMMUNIZATION
inferredcites →https://doi.org/10.1097/00007890-199001000-00015openalex-snapshot
INTRAVENOUS IMMUNOGLOBULIN INFUSIONS FOR THE PROPHYLAXIS OF SECONDARY CYTOMEGALOVIRUS INFECTION
inferredcites →https://doi.org/10.1097/00007890-199102000-00032openalex-snapshot
CYTOMEGALOVIRUS SEROLOGIC STATUS AND POSTOPERATIVE INFECTION CORRELATED WITH RISK OF DEVELOPING CHRONIC REJECTION AFTER PULMONARY TRANSPLANTATION
inferredcites →https://doi.org/10.1097/00007890-199402000-00005openalex-snapshot
VIRAL PROPHYLAXIS IN COMBINED PANCREAS-KIDNEY TRANSPLANT RECIPIENTS
inferredcites →https://doi.org/10.1097/00007890-199403270-00019openalex-snapshot
A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2
inferredcites →https://doi.org/10.1097/00007890-199412000-00006openalex-snapshot
MULTICENTER TRIAL OF TOWNE STRAIN ATTENUATED VIRUS VACCINE IN SERONEGATIVE RENAL TRANSPLANT RECIPIENTS
inferredcites →https://doi.org/10.1097/01.tp.0000183970.71366.daopenalex-snapshot
Pre-emptive Treatment for Cytomegalovirus Viremia to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients
inferredcites →https://doi.org/10.1111/j.1399-0012.1992.tb00135.xopenalex-snapshot
A randomized trial with two anti‐CMV hyperimmune globulins in the prevention of CMV disease in CMV‐negative renal transplant patients
inferredcites →https://doi.org/10.1111/j.1399-0012.1994.tb00935.xopenalex-snapshot
Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients ‐ A meta‐analysis
inferredcites →https://doi.org/10.1111/j.1399-0012.1996.tb00433.xopenalex-snapshot
Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection
inferredcites →https://doi.org/10.1111/tri.1992.5.s1.146openalex-snapshot
CMV prophylaxis after renal transplantation with immunoglobulin or CMV-hyperimmunoglobulin - a prospective clinical trial
inferredcites →https://doi.org/10.1128/aac.39.7.1643openalex-snapshot
Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3
inferredcites →https://doi.org/10.1136/bmj.309.6964.1286openalex-snapshot
Systematic Reviews: Identifying relevant studies for systematic reviews
inferredcites →https://doi.org/10.1136/bmj.319.7211.670openalex-snapshot
What is meant by intention to treat analysis? Survey of published randomised controlled trials
inferredcites →https://doi.org/10.1136/bmj.327.7414.557openalex-snapshot
Measuring inconsistency in meta-analyses
inferredcites →https://doi.org/10.1159/000045315openalex-snapshot
Hyperimmune Globulin Prophylaxis for Cytomegalovirus Infection in Renal Transplantation
inferredcites →https://doi.org/10.1159/000169175openalex-snapshot
CMV Prophylaxis in High-Risk Renal Transplant Patients (D+/R-) by Acγclovir with or without Hyperimmune (CMV) Immunoglobulins: A Prospective Study
inferredcites →https://doi.org/10.1681/asn.v2101469openalex-snapshot
The effect of polyimmune gammaglobulin for prophylaxis against reactivation cytomegalovirus infection in kidney and kidney/pancreas transplant recipients.
inferredcites →https://doi.org/10.7326/0003-4819-114-7-525openalex-snapshot
Effect of Towne Live Virus Vaccine on Cytomegalovirus Disease after Renal Transplant
inferredcites →https://doi.org/10.7326/0003-4819-119-10-199311150-00004openalex-snapshot
Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4772305openalex-extracted
Gastrointestinal Cytomegalovirus Infection in a Transplanted Patient with Negative Serum Viral Load: Case Report
inferred← citeshttps://doi.org/10.1002/14651858.cd003774.pub3openalex-snapshot
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1002/14651858.cd003774.pub4openalex-snapshot
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1002/14651858.cd003774.pub5openalex-snapshot
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1002/9780470714171.ch14openalex-snapshot
Current Strategies and Future Directions in Cytomegalovirus (CMV) Pneumonitis
inferred← citeshttps://doi.org/10.1002/jmv.23964openalex-snapshot
Prophylaxis versus pre-emptive treatment for prevention of cytomegalovirus infection in CMV-seropositive orthotopic liver-transplant recipients
inferred← citeshttps://doi.org/10.1002/lt.22144openalex-snapshot
Cytomegalovirus infection after liver transplantation
inferred← citeshttps://doi.org/10.1007/978-3-319-28797-3_25openalex-snapshot
Cytomegalovirus Infection After Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-319-28797-3_7openalex-snapshot
Risk and Epidemiology of Infections After Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-540-79086-0_8openalex-snapshot
Interferons and Their Use in Persistent Viral Infections
inferred← citeshttps://doi.org/10.1007/s00246-017-1572-2openalex-snapshot
Potential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis
inferred← citeshttps://doi.org/10.1007/s00281-014-0448-2openalex-snapshot
CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity
inferred← citeshttps://doi.org/10.1007/s11239-011-0662-xopenalex-snapshot
Human cytomegalovirus infection and atherothrombosis
inferred← citeshttps://doi.org/10.1007/s11894-008-0077-9openalex-snapshot
Gastrointestinal cytomegalovirus disease in the immunocompromised patient
inferred← citeshttps://doi.org/10.1007/s40265-018-0943-1openalex-snapshot
New Developments in the Management of Cytomegalovirus Infection After Transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-12-374432-6.00034-8openalex-snapshot
Human Immunoglobulin Preparations
inferred← citeshttps://doi.org/10.1016/b978-0-12-397164-7.00037-9openalex-snapshot
Human Immunoglobulin Preparations
inferred← citeshttps://doi.org/10.1016/b978-0-12-801734-0.00052-7openalex-snapshot
Kidney Transplantation
inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00308-8openalex-snapshot
Nosocomial Herpesvirus Infections
inferred← citeshttps://doi.org/10.1016/j.biologicals.2017.09.004openalex-snapshot
Binding and neutralizing anti-cytomegalovirus activities in immune globulin products
inferred← citeshttps://doi.org/10.1016/j.canlet.2013.09.004openalex-snapshot
Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review
inferred← citeshttps://doi.org/10.1016/j.idc.2011.07.005openalex-snapshot
Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases
inferred← citeshttps://doi.org/10.1016/j.idc.2011.07.008openalex-snapshot
Interferons as Therapeutic Agents for Infectious Diseases
inferred← citeshttps://doi.org/10.1016/j.idc.2013.02.005openalex-snapshot
Management Strategies for Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
inferred← citeshttps://doi.org/10.1016/j.immuni.2023.10.009openalex-snapshot
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer
inferred← citeshttps://doi.org/10.1016/j.paed.2013.11.003openalex-snapshot
Central nervous system herpesvirus infections
inferred← citeshttps://doi.org/10.1016/j.paed.2018.04.003openalex-snapshot
Central nervous system herpesvirus infections
inferred← citeshttps://doi.org/10.1016/j.transproceed.2024.05.005openalex-snapshot
Gastrointestinal Cytomegalovirus Infection in a Transplantation Recipient With a Negative Serum Viral Load: Case Report
inferred← citeshttps://doi.org/10.1016/j.trim.2008.12.004openalex-snapshot
Delayed onset CMV disease in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1016/j.trre.2014.01.001openalex-snapshot
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1016/j.ucl.2021.12.010openalex-snapshot
Immunosuppression Therapy in Kidney Transplantation
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.05.011openalex-snapshot
Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.09.038openalex-snapshot
Vaccine administration in children with chronic kidney disease
inferred← citeshttps://doi.org/10.1016/s0140-6736(11)60435-2openalex-snapshot
A cytomegalovirus vaccine tames the troll of transplantation
inferred← citeshttps://doi.org/10.1016/s0304-5412(14)70722-xopenalex-snapshot
Infecciones por el virus de Epstein-Barr y citomegalovirus
inferred← citeshttps://doi.org/10.1016/s2213-2600(13)70162-0openalex-snapshot
Respiratory infections in patients with cystic fibrosis undergoing lung transplantation
inferred← citeshttps://doi.org/10.1038/s44321-026-00372-1openalex-snapshot
A viral glycoprotein targets IgG+ memory B cells to mediate humoral immune evasion
inferred← citeshttps://doi.org/10.1053/j.ackd.2012.01.002openalex-snapshot
Evidence-Based Practice in Nephrology: Systematic Reviews
inferred← citeshttps://doi.org/10.1080/14740338.2019.1662787openalex-snapshot
Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation
inferred← citeshttps://doi.org/10.1080/17512433.2018.1501557openalex-snapshot
Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1093/infdis/jiy229openalex-snapshot
Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood Donors
inferred← citeshttps://doi.org/10.1097/ipc.0b013e31819b8d27openalex-snapshot
Management of Cytomegalovirus Infection After Renal Transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000005374openalex-snapshot
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1097/tp.0b013e3181a19cdaopenalex-snapshot
A Hybrid Strategy for the Prevention of Cytomegalovirus-Related Complications in Pediatric Liver Transplantation Recipients
inferred← citeshttps://doi.org/10.1097/tp.0b013e3181ffba7eopenalex-snapshot
Cytomegalovirus Prevention and Long-Term Recipient and Graft Survival in Pediatric Heart Transplant Recipients
inferred← citeshttps://doi.org/10.1111/ajt.12103openalex-snapshot
Cytomegalovirus in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1111/bjh.12363openalex-snapshot
Management of cytomegalovirus infection in haemopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1111/ctr.13512openalex-snapshot
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
inferred← citeshttps://doi.org/10.1111/ctr.13666openalex-snapshot
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies
inferred← citeshttps://doi.org/10.1111/ctr.14372openalex-snapshot
A call for transplant stewardship: The need for expanded evidence‐based evaluation of induction and biologic‐based cost‐saving strategies in kidney transplantation and beyond
inferred← citeshttps://doi.org/10.1111/ctr.14848openalex-snapshot
Combination prophylaxis in CMV high risk heart transplant recipients: A single center experience
inferred← citeshttps://doi.org/10.1111/ctr.70255openalex-snapshot
Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell and in Solid Organ Transplantation: Updated Recommendations by the GITMO, SITO, SIMIT, and AMCLI Italian Societies
inferred← citeshttps://doi.org/10.1111/j.1399-0012.2008.00942.xopenalex-snapshot
Hematologic complications of anti‐CMV therapy in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1111/j.1399-0012.2011.01459.xopenalex-snapshot
The impact of CMV prevention on long‐term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database
inferred← citeshttps://doi.org/10.1111/j.1399-3046.2007.00868.xopenalex-snapshot
Hepatic artery reconstruction with inferior mesenteric vein graft in pediatric living donor liver transplantation
inferred← citeshttps://doi.org/10.1111/j.1399-3046.2008.00907.xopenalex-snapshot
Optimal approach to prevent CMV disease
inferred← citeshttps://doi.org/10.1111/j.1600-6143.2009.02834.xopenalex-snapshot
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1111/tid.14183openalex-snapshot
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023
inferred← citeshttps://doi.org/10.1111/trf.13906openalex-snapshot
A two‐step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus
inferred← citeshttps://doi.org/10.1128/9781555816803.ch7openalex-snapshot
Cytomegalovirus Infection in Transplantation
inferred← citeshttps://doi.org/10.1128/jvi.02077-18openalex-snapshot
Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus
inferred← citeshttps://doi.org/10.1136/dtb.2009.07.0032openalex-snapshot
I.V. immunoglobulin therapy for infectious diseases
inferred← citeshttps://doi.org/10.1172/jci45449openalex-snapshot
Cytomegalovirus: pathogen, paradigm, and puzzle
inferred← citeshttps://doi.org/10.1371/journal.ppat.1004131openalex-snapshot
Human Cytomegalovirus Fcγ Binding Proteins gp34 and gp68 Antagonize Fcγ Receptors I, II and III
inferred← citeshttps://doi.org/10.1515/jpm.2009.127openalex-snapshot
Guidelines on CMV congenital infection
inferred← citeshttps://doi.org/10.1517/14656566.2010.492395openalex-snapshot
Strategies for managing cytomegalovirus in transplant recipients
inferred← citeshttps://doi.org/10.1517/14656566.9.14.2409openalex-snapshot
Pharmacotherapy of post-transplant viral infections
inferred← citeshttps://doi.org/10.2165/10898540-000000000-00000openalex-snapshot
New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation
inferred← citeshttps://doi.org/10.21926/obm.transplant.2102145openalex-snapshot
Cytomegalovirus in Lung Transplant
inferred← citeshttps://doi.org/10.2215/cjn.04410512openalex-snapshot
Common Infections in Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.2217/fmb.12.109openalex-snapshot
Interplay Between CMVs and Interferon Signaling: Implications for Pathogenesis and Therapeutic Intervention
inferred← citeshttps://doi.org/10.2217/imt.09.82openalex-snapshot
Immune-Based Therapies for Cytomegalovirus Infection
inferred← citeshttps://doi.org/10.2217/imt.15.70openalex-snapshot
Therapeutic Strategies for Cytomegalovirus in Allogeneic Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2014.00552openalex-snapshot
Immunity to Cytomegalovirus in Early Life
inferred← citeshttps://doi.org/10.3389/fped.2023.1098434openalex-snapshot
Prevention and management of CMV infection in pediatric solid organ transplant recipients
inferred← citeshttps://doi.org/10.3390/cells13161338openalex-snapshot
Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target
inferred← citeshttps://doi.org/10.3390/microorganisms11010032openalex-snapshot
Evaluation of Two Different CMV-Immunoglobulin Regimens for Combined CMV Prophylaxis in High-Risk Patients following Lung Transplant
inferred← citeshttps://doi.org/10.3390/v15071595openalex-snapshot
Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients
inferred← citeshttps://doi.org/10.3748/wjg.14.4749openalex-snapshot
Cytomegalovirus infection after liver transplantation: Current concepts and challenges
inferred← citeshttps://doi.org/10.3947/ic.2024.0016openalex-snapshot
Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients: Guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation
inferred← citeshttps://doi.org/10.4254/wjh.v6.i6.370openalex-snapshot
Management of cytomegalovirus infection and disease in liver transplant recipients
inferred← citeshttps://doi.org/10.5222/tmcd.2013.077openalex-snapshot
Staphylococcus aureus Türlerinde Biyofilm ve Biyofilm Oluşumundan Sorumlu Genler
inferred← citeshttps://doi.org/10.5222/tmcd.2013.084openalex-snapshot
CMV Profilaksisi Alan Böbrek Nakli Olan Hastalarda CMV Enfeksiyonu Sıklığı ve Risk Faktörlerinin Değerlendirilmesi
inferred← citeshttps://doi.org/10.5222/tmcd.2013.090openalex-snapshot
Dokuz Eylül Üniversitesi Tıp Fakültesi Hastanesi Mikoloji Laboratuvarına Gönderilen Kazıntı Örneklerinin Direk Bakı ve Kültür Sonuçları
inferred← citeshttps://doi.org/10.5222/tmcd.2013.097openalex-snapshot
Bazı Liken Örneklerinin Antimikrobiyal Özelliklerinin Belirlenmesi
inferred← citeshttps://doi.org/10.5222/tmcd.2013.104openalex-snapshot
Dispeptik Yakınmalı Hastalarda Helicobacter pylori Virulans Genleri ile Endoskopik Bulguların Karşılaştırılması
inferred← citeshttps://doi.org/10.5222/tmcd.2013.112openalex-snapshot
İmmünsüpresif Bir Hastada Chryseobacterium meningosepticum'un Neden Olduğu Bakteriyemi Olgusu
inferred← citeshttps://doi.org/10.5222/tmcd.2013.115openalex-snapshot
Corynebacterium pseudodiphtheriticum Pnömonisi: Bir Olgu Sunumu
inferred← citeshttps://doi.org/10.5772/16759openalex-snapshot
Infectious Complications in Kidney Transplantation
inferred← citeshttps://doi.org/10.5772/16991openalex-snapshot
CMV Infection in CMV-Seropositive Kidney Transplant Recipients
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.